dinoprost and Neoplasms

Inflammation is a major cause of cancer and may condition its progression. The deregulation of the cyclooxygenase (COX) pathway is implicated in several pathophysiological processes, including inflammation and cancer. Although, its targeting with nonsteroidal antiinflammatory drugs (NSAIDs) and COX-2 selective inhibitors has been investigated for years with promising results at both preventive and therapeutic levels, undesirable side effects and the limited understanding of the regulation and functionalities of the COX pathway compromise a more extensive application of these drugs. Epigenetics is bringing additional levels of complexity to the understanding of basic biological and pathological processes. The deregulation of signaling and biosynthetic pathways by epigenetic mechanisms may account for new molecular targets in cancer therapeutics. Genes of the COX pathway are seldom mutated in neoplastic cells, but a large proportion of them show aberrant expression in different types of cancer. A growing body of evidence indicates that epigenetic alterations play a critical role in the deregulation of the genes of the COX pathway. This review summarizes the current knowledge on the contribution of epigenetic processes to the deregulation of the COX pathway in cancer, getting insights into how these alterations may be relevant for the clinical management of patients.

Topics: Dinoprost; Dinoprostone; Epigenesis, Genetic; Epoprostenol; Gene Silencing; Humans; Neoplasms; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Signal Transduction; Thromboxane A2

Topics: Chemical Phenomena; Chemistry; Dinoprost; Gastric Mucosa; Humans; Neoplasms; Platelet Aggregation; Prostaglandins; Prostaglandins F; Respiratory Tract Diseases; Schizophrenia; Vasodilator Agents

Six patients with incurable malignancies were originally treated with vitamin E, 3200 IU/day for fourteen days, followed by the same dose of vitamin E daily plus LCV (20 mg/m2 i.v. bolus daily x 5) with 5FU (425 mg/m2 i.v. bolus immediately following LCV). The same schedule of LCV and 5FU was repeated 4 weeks later, then every 5 weeks indefinitely. When 3 of the first 6 had grade 3/4 toxicity, six more patients were treated on the identical drugs and schedule. Seven of twelve total patients had one or more grade 3/4 toxicities. Neutropenia, abdominal pain, and diarrhea were most common. No patient had a documented response, though seven patients did have stable disease. Though the combination of vitamin E and chemotherapy was toxic, this trial demonstrated maximal therapeutic doses of vitamin E can be combined with standard 5FU and LCV, without significantly increasing the side effects of the chemotherapy itself.

Topics: Abdominal Pain; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Dinoprost; Dose-Response Relationship, Drug; F2-Isoprostanes; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Neoplasms; Neutropenia; Vitamin E

Oxidative damage to lipids may be involved in the etiology of atherosclerosis, cardiovascular disease in general, and cancer. The soy isoflavone phytoestrogens, genistein and daidzein, and equol (a daidzein metabolite produced by intestinal microflora) are antioxidants in vitro; equol is a particularly good inhibitor of LDL oxidation and membrane lipid peroxidation.. We sought to investigate the effects of a diet enriched with soy containing isoflavones on in vivo biomarkers of lipid peroxidation and resistance of LDL to oxidation, compared with a diet enriched with soy from which the isoflavones had been extracted.. : A randomized, crossover design was used to compare diets enriched with soy that was low or high in isoflavones in 24 subjects. Plasma concentrations of an F(2)-isoprostane, 8-epi-prostaglandin F(2)(alpha) (8-epi-PGF(2)(alpha)), a biomarker of in vivo lipid peroxidation, and resistance of LDL to copper-ion-induced oxidation were determined.. Plasma concentrations of 8-epi-PGF(2)(alpha) were significantly lower after the high-isoflavone dietary treatment than after the low-isoflavone dietary treatment (326 +/- 32 and 405 +/- 50 ng/L, respectively; P = 0.028) and the lag time for copper-ion-induced LDL oxidation was longer (48 +/- 2.4 and 44 +/- 1.9 min, respectively; P = 0.017). Lag time for oxidation of unfractionated plasma and plasma concentrations of malondialdehyde, LDL alpha-tocopherol, polyunsaturated fatty acids, and isoflavonoids did not differ significantly between dietary treatments.. Consumption of soy containing naturally occurring amounts of isoflavone phytoestrogens reduced lipid peroxidation in vivo and increased the resistance of LDL to oxidation. This antioxidant action may be significant with regard to risk of atherosclerosis, cardiovascular disease in general, and cancer.

Topics: Adult; Cardiovascular Diseases; Cross-Over Studies; Diet; Dinoprost; Estrogens, Non-Steroidal; F2-Isoprostanes; Female; Glycine max; Humans; Isoflavones; Lipid Peroxidation; Lipoproteins, LDL; Male; Neoplasms; Phytoestrogens; Plant Preparations

Topics: Adiponectin; Animals; Colitis; Colon; Cytokines; Dextran Sulfate; Dinoprost; Dinoprostone; Growth Hormone-Releasing Hormone; Male; Mice, Inbred C57BL; Mice, Knockout; Neoplasms

Reactive oxygen species may be involved in epigenetic gene activation or silencing. We aimed to identify CpG sites, at which DNA methylation is related to urinary 8-isoprostane levels (biomarker of lipid peroxidation) and cancer or mortality outcomes. This investigation was based on a German, population-based cohort with linkage to cancer and mortality registry data (2000-2016).. Blood DNA methylation in promoter regions of 519 genes, known to be involved in pathways from oxidative stress (OS) to cancer, was obtained at the cohort's baseline examination. Inverse associations of DNA methylation at cg25365794 (ALOXE3) and cg08862778 (MTOR) with 8-isoprostane levels were observed in a derivation set (n = 1000) and validated in two independent subsets of the cohort (n = 548 and n = 741). Multivariate regression models were used to evaluate the associations of DNA methylation at the two CpG sites with lung, colorectal, prostate, breast, and overall cancer incidence as well as CVD, cancer, and all-cause mortality. DNA methylation at cg25365794 (ALOXE3) was inversely associated with lung and prostate cancer incidence. DNA methylation at cg08862778 (MTOR) was associated with a 43% lower breast cancer incidence in the top vs. bottom tertile.. The finding for ALOXE3 may not be causal. As ALOXE3 is mainly expressed in skin tissue, the observed association might reflect the fact that both DNA methylation at the ALOXE3 gene and urinary 8-isoprostane concentrations depend on the level of OS in tissues. Contrarily, the finding for the MTOR gene and breast cancer is biologically plausible because the MTOR protein plays an important role in PI3K/Akt signaling, which is a pathway related to cancer development and cell senescence.

Topics: Aged; Cohort Studies; CpG Islands; Dinoprost; DNA Methylation; Epigenesis, Genetic; Female; Genetic Association Studies; Humans; Incidence; Lipoxygenase; Male; Middle Aged; Neoplasms; Oxidative Stress; TOR Serine-Threonine Kinases

An increasing number of clinical studies highlight the importance of the inflammatory mediator prostaglandin F2 α (PGF(2α)). Prostaglandin F2 α activity has been suggested to play pivotal roles in the development of cardiovascular diseases and cancer. However, whether systemic PGF(2α) concentrations may signal mortality is unknown. The aim was to evaluate in vivo PGF(2α) formation, by measuring urinary 15-keto-dihydro-PGF(2α), and mortality risk in a community setting.. Urinary 15-keto-dihydro-PGF(2α) was measured in a Swedish population of 670 men (aged 77-78 years) and the participants were followed up for a median of 9.7 years (383 died, among them 156 of cardiovascular causes and 102 of cancer). In Cox regression models, urinary 15-keto-dihydro-PGF(2α) was significantly associated with cardiovascular mortality [multivariate hazard ratio (HR) for 1 SD increase of urinary 15-keto-dihydro-PGF(2α): 1.18; 95% CI:1.04-1.34; P = 0.01) independent of established cardiovascular risk factors including C-reactive protein. Urinary 15-keto-dihydro-PGF(2α) was also independently associated with total mortality (multivariate HR for 1 SD increase of urinary 15-keto-dihydro-PGF(2α): 1.11; 95% CI: 1.01-1.21; P = 0.03). The combination of 15-keto-dihydro-PGF(2α) concentrations above the median and high serum high-sensitive C-reactive protein (>3 mg/L) was independently associated with a two-fold increased risk of cancer and total mortality (P = 0.02 and P < 0.001, respectively).. This is the first study to show that the inflammatory mediator PGF(2α) was independently associated with mortality and specifically cardiovascular mortality 10 years later. The results are in line with the emerging evidence of the importance of the inflammatory mediator PGF(2α) in fatal cardiovascular disease.

Topics: Aged; Cardiovascular Diseases; Cause of Death; Dinoprost; Humans; Longitudinal Studies; Male; Neoplasms; Risk Factors; Sweden

Prostaglandins (PGs), important modulators in bone biology, may also contribute to tumor formation and progression in human osteosarcoma. 15-Deoxy-Δ(12,14)-PGJ(2) (15d-PGJ(2)), a metabolite of PGD(2) and PPARγ-ligand, exerts a panel of biological activities via receptor-dependent and -independent mechanisms. As inducible cyclooxygenase-2 (Cox-2) is a candidate inflammatory marker in human osteosarcoma and a rate-limiting enzyme in PG biosynthesis, this study aimed at investigating intracellular redox status and signaling cascades leading to Cox-2 induction in human MG-63 osteosarcoma cells. 15d-PGJ(2) induced the accumulation of reactive oxygen species (ROS) that in turn may lead to upregulation of Cox-2 via two different routes in a PPARγ-independent manner. First, phosphorylation of p38 MAPK directly enhances Cox-2 expression by promoting mRNA stability. Second, 15d-PGJ(2) induces activation of epidermal growth factor receptors and downstream activation of Cox-2 via phosphorylation of p42/44 MAPK. Glutathione precursor molecules reversed enhanced ROS levels and Cox-2 expression. Functional activity of Cox-2 expression was tested by measurement of PGE(2) and PGF(2α). The synthetic compound 9,10-dihydro-15d-PGJ(2) lacking the α,β-unsaturated carbonyl group in the cyclopentenone ring did not exhibit the cellular responses observed with 15d-PGJ(2). We conclude that the electrophilic carbon atom of 15d-PGJ(2) is responsible for alterations in intracellular redox status and Cox-2 expression.

Topics: Animals; Cell Line, Tumor; Cyclooxygenase 2; Dinoprost; Dinoprostone; ErbB Receptors; Gene Expression; Glutathione; Humans; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasms; Osteosarcoma; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prostaglandin D2; Reactive Oxygen Species; RNA Stability; Signal Transduction; Up-Regulation

Topics: Adult; Aged; Alprostadil; Connective Tissue Diseases; Diabetes Mellitus; Dinoprost; Factor Analysis, Statistical; Female; Humans; Kidney Failure, Chronic; Lung Diseases, Obstructive; Male; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Middle Aged; Neoplasms; Prostaglandins E; Prostaglandins F

Prostaglandins have been shown to be important modulators of haemostatis , immune responses, and growth of normal and neoplastic cells. In order to investigate the cell origin and metabolic profile of the endogenous prostaglandins in human tumours, a convenient extraction and gas chromatographic method for measuring the various classes of prostaglandins was developed. Infiltrating macrophages from human tumours were isolated using adherence to plastic. Macrophage-enriched and macrophage-depleted cell populations were then cultured in vitro and the media supernatant was studied for the presence of prostaglandins E1, E2, F2 alpha, and 6-keto-F1 alpha (the spontaneous breakdown product of prostacyclin, PGI2). Routinely, 1 ml of medium containing 10(6) cells was studied. The eicosanoids were extracted using commercially available octadecylsilyl silica reversed-phase columns prior to derivatization. Standards and samples were prepared as pentafluorobenzyl ester (methoxime) trimethylsilyl ether derivatives for analysis on an OV-101 (25 m X 0.2 mm) fused-silica capillary column. Recovery of standards ranged from 93% to 37%, with linear recovery in all instances (regression coefficients greater than 0.98). Detection limits were 20 pg for each of the prostaglandins. Analysis of cell subpopulations from six human tumours revealed that infiltrating macrophages produce various prostaglandin profiles and are largely responsible for the prostaglandin production in human cancer. The described analytical method is the first application of high-resolution gas chromatography with electron-capture detection to the quantitative profiling of prostaglandins from human cell culture.

Topics: Alprostadil; Cells, Cultured; Chromatography, Gas; Culture Media; Dinoprost; Dinoprostone; Epoprostenol; Humans; In Vitro Techniques; Neoplasms; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Prostaglandins E; Prostaglandins F

The cytotoxic effect of prostaglandin (PG) D2, PGE1 and PGF2 alpha was examined on human osteosarcoma cells (KSu cell line) in vitro, and PGD2 was most effective. DNA, RNA and protein syntheses of KSu cells were also found to be inhibited by PGD2 at a concentration of 5 micrograms/ml. Furthermore, the proliferation of various human malignant tumor cells was inhibited by PGD2 without exception so far. These results suggest that PGD2 shows an anti-neoplastic effect on a variety of human malignant tumor cells.

Topics: Antineoplastic Agents; Cell Division; Cell Line; Dinoprost; Dinoprostone; Humans; Neoplasm Proteins; Neoplasms; Nucleic Acids; Osteosarcoma; Prostaglandin D2; Prostaglandins D; Prostaglandins E; Prostaglandins F

Topics: Carboprost; Cell Division; Cell Line; Dinoprost; DNA, Neoplasm; Humans; Neoplasm Proteins; Neoplasms; Prostaglandins F; Prostaglandins F, Synthetic; RNA, Neoplasm